Online Corporate Workshops (OCWs) are free for all attendees. They are a year-round extension of the popular Corporate Workshops presented each year at the AMP Annual Meeting. They are free to the public and therefore are valuable opportunities for everyone to learn to learn from industry representatives and scientific experts about the latest advances and instrumentation relevant to molecular diagnostics and research. OCWs are presented on weekday afternoons for one hour, and are conducted by commercial companies. Upcoming OCWs will be announced to AMP members on CHAMP, including registration information, as well as posted on this webpage.
Translatability of Tumor Inflammation Gene Signatures & Blood-Based Biomarkers of Immuno-Oncology
Speakers:
Nancy Zhang, MD
Associate Director, Pharmacodiagnostics and Precision Medicine, BMS
and
Jonathan Baden
Senior Director Pharmacodiagnostic, BMS
Access is available for a limited time. There is no fee or membership requirement to access archived OCWs.
Treating Late Stage Cancer Patients During a Pandemic: An International and Multidisciplinary Perspective
Presenters:
David Huntsman, MD, FRCPC, FCCMG
Chew Wei Memorial Professor of Gynaecologc Oncology,
Professor: Departments of Pathology and Laboratory Medicine and Obstetrics and Gynaecology: UBC (CANADA)
William G. Morice, II, M.D., Ph.D.
Chair of the Department of Laboratory Medicine and Pathology
President of Mayo Labs Rochester, MN, (U.S.A)
Joerg Kriegsmann
Medical Director of Sonic Germany, aka Molecular Pathologie Trier, (GERMANY)
Rosalyn Juergens, B.S. (Hons), MD., PhD
Associate Professor, Department of Oncology, McMaster University
Adjunct Assistant Professor, Department of Oncology, The Johns Hopkins Medical Institute (CANADA).
Liquid Biopsy Testing Strategies for Patients with Metastatic NSCLC
Presenter:
John W. Longshore, PhD, FACMG
Director, Molecular Pathology Laboratory
Atrium Health, formerly Carolinas HealthCare System
Carolinas Pathology Group
Charlotte, North Carolina
Tackling COVID-19 through syndromic testing – QIAstat-Dx Respiratory SARS-CoV-2 Panel
Presenter:
Davide Manissero, MD, MRCPCH, MSc, DTM&H
VP, Head of Medical Affairs & Chief Medical Officer
Infection & Immune Diagnostics, QIAGEN
Molecular Testing for Alterations in DNA Damage Repair Pathway Genes in Ovarian & Prostate Cancer: Why, Who, & How to Test
Presenter:
Samuel Caughron, MD, FCAP
Pathologist, President & CEO, MAWD Pathology Group
Chair of Pathology & Medical Director of Clinical Laboratory, Advent Health Kansas City
Learn how to implement a streamlined, single NGS workflow for the analysis of DNA and RNA – all from a single sample
Presenter:
Sylvia Herold, PhD
Institut für Pathologie
Universitätsklinikum Dresden
Current and Emerging Biomarkers: Science, Technology, & Practicalities
Presenter:
Tabetha Sundin, PhD, HCLD (ABB), MB(ASCP)
Scientific Director
Molecular Diagnostics & Serology
Sentara Healthcare
Utility of NGS Assays for the Evaluation of Lymphoid Malignancies
Presenters:
Yury Monczak, PhD, Scientific Co-Director, Molecular Pathology Center, McGill University Health Center, Jewish General Hospital, Assistant Professor, McGill University
Bevan Tandon MD, Director, Cancer Genomics, BioReference Laboratories, an OPKO Health Company,
New Tools to Overcome Challenges in Vaginitis Diagnosis and Treatment
Presenter: Jane Schwebke, MD, Professor of Medicine – Infectious Disease Division, University of Alabama - Birmingham
The Power of ONE: Introducing a Novel 1-Day Workflow for Simultaneous High-Sensitivity Analysis of DNA Variants & RNA Fusions
Presenter:
Jonathan Shaffer, PhD, MBA, Associate Director, NGS Assay Research & Development, QIAGEN
Experience the Power of ONE: Simultaneous Detection of DNA Variants & RNA Fusions in 1-Day Workflow from Sample to Sequencing
Presenters:
George J. Quellhorst, Jr., PhD Associate Director, R&D, QIAGEN;
Andrew Cassidy, PhD, Marketing Project Manager, Enterprise Genomic Services, QIAGEN
Implementation of a Cost-Effective NGS Program in a Laboratory with Limited Resources.
Presenters:
Yassmine Akkari, PhD, Legacy Health
Eva Szarek, PhD, QIAGEN
Minimal Residual Disease Detection of B-lymphoid and Plasma Cell Neoplasm Using a NGS-Based Clonal IGH Rearrangement Assay
Presenters:
Caleb Ho, MD Memorial Sloan Kettering Cancer Center
Ryan Schmidt, MD, PhD, University of Southern California/Children’s Hospital, Los Angeles
A Pathologist's Guide to Companion Diagnostics and Precision Medicine in Oncology
Presenters:
Anjen Chenn, MD, PhD, Sr Director Molecular Diagnostics, LabCorp
Jennifer Quigley, Director Oncology Product Commercialization, LabCorp – Integrated Oncology
Benjamin Chaffey, PhD, Global Product Manager, QIAGEN
Download Video (65MB)
Syndromic Respiratory Testing in a Dynamic Reimbursement Landscape
Presenters:
James Dunn, PhD,Director, Medical Microbiology & Virology Lab, Texas Children’s & Baylor Hospitals
Paul Radensky, MD, JD, Principal, McDermott Consulting
Download Video (59MB)
Pathology Leadership in Biomarker Testing: Pre-Analytical Phase
Presenter: Michelle Shiller, DO, Baylor University Medical Center
Download Video (MP4, 450MB)
Mutational Signatures in Cytogenetics Risk Groups of Newly Diagnosed Acute Myeloid Leukemia (AML) and Myelodysplastic Syndrome (MDS)
Presenter: Robyn Sussman, PhD, Hospital of the University of Pennsylvania
Moderator: Jung Doh, PhD, Beckman Coulter Life Sciences
Download Video (WMV, 23MB)
Handout (PDF)
Why Liquid Biopsy is Important in Clinical Routine...
Presenter: Ron van Schaik
Rotterdam, The Netherlands
Download Video (MP4)
ALK-EML4 Fusions in ctDNA of Lung Cancer Patients in Clinical Practice
Presenter: Antoinette Lemoine
Paris, France
Download Video (MP4)
Complete Suite of NGS Clonality Assays with Bioinformatics - Identification and Tracking Patient-specific Clones
Presenters: Presha Shah, PhD and Kasey Hutt, PhD
Invivoscribe, San Diego, CA
Download Video (WMV, 52MB)
LymphoTrack Portfolio - Ion PGM
Mycoplasma genitalium Infection: An Emerging Sexually Transmitted Infection
Presenter: William M. Geisler MD, MPH
University of Alabama at Birmingham
Download Video (MP4, 550MB)
Handout
NGS Clonality Testing: Assessing Clonality Status, Somatic Hypermutation and Monitoring Minimum Residual Disease (MRD)
Presenter: Maria Arcila, MD
Moderator: Jeff Miller, PhD
Download Video (WMV, 75MB)
Handout
Challenges in Genomic Aberration Detection and Interpretation in Solid Tumors and Evidence-based Approaches for Targeted Therapy
Presenters: Nevenka Dimitrova, PhD and Sheryl Elkin, PhD
Moderator: Autri Dutta, PhD
Download Video (WMV, 58MB)
Handout
Genetics in Clinical Diagnostics
Presenter: Michael Snyder, PhD
Moderator: Nevenka Dimitrova, PhD
Download Video (WMV, 50MB)
(Audio starts at 1:15)
Handout
Monitoring Deep Molecular Response: A Sensitive and Robust FDA Cleared Assay for CML
Presenters: Bernard F. Andruss, PhD and Y. Lynn Wang, MD, PhD, FCAP
Moderator: Ninad Pendsé, MBA
Download Video (WMV, 63MB)
Comprehensive Tumor Characterization Using Augmented NGS
Presenter: Christelle Johnson, PhD
Moderator: Erin Newburn, PhD
Download Video (WMV, 32MB)
Achieving High Diagnostic Yield for Clinically Relevant Genes: How to ‘ACE' Exome Sequencing
Presenter: Heather Wetzel, MS, LCGC
Moderator: Felicia Hawthorne, PhD
Download Video (WMV, 42MB)
Diamond Partner
Diamond Partner
Gold Partner
Gold Partner
Platinum Partner
Gold Partner
Gold Partner
Gold Partner
Gold Partner
Gold Partner
Gold Partner
Gold Partner
Diamond Partner
Silver Partner
Gold Partner
Gold Partner
Silver Partner